Catalyst Wire Dossier Catalyst Wire Dossier

NKF-INS(A)

· Xentria, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKF-INS(A), covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid® [Phase 1]

See pricing